Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc. (APVO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · APVO · as of Jun 8, 2026
Key Statistics
Explore Aptevo Therapeutics Inc. Data
apvo stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
Competitors & Peers
apvo competitorsAPVO
ABP
BCDA
CERO
EPIX
ERNAStock Performance
Full HistoryAbout Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company primarily focused on pioneering immunotherapeutic agents for a variety of cancer treatments across the United States. Its foremost in…
what is aptevo therapeutics inc. · apvo stock overview · aptevo therapeutics inc. company profile · who is aptevo therapeutics inc. ceo · apvo NASDAQ · aptevo therapeutics inc. headquarters · aptevo therapeutics inc. business segments
About Stock Overview & Key Data
Aptevo Therapeutics Inc. (APVO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 20, 2016. As of the latest trading session, APVO stock price is $4.89, with a market capitalization of $10.7M. The stock has returned -94.20% over the past 12 months and -48.14% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Aptevo Therapeutics Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Aptevo Therapeutics Inc. reported revenue of — and net income of -$26.0M. For detailed data — including Aptevo Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aptevo Therapeutics Inc. (APVO) stock price is $4.89. The stock is traded on NASDAQ under the ticker symbol APVO. The 52-week range is $3.80 – $235.98.